Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The second quarter ended June 30, not in July.
UPDATE 1-U.S. FDA clears Abbott's blood test for concussions
Tue, March 7, 2023 at 9:30 AM EST·1 min read
March 7 (Reuters) - The U.S. Food and Drug Administration has cleared Abbott Laboratories' blood test that would help doctors assess traumatic brain injury (TBI), commonly known as concussions, the company said on Tuesday.
The clearance marks the first commercially available laboratory blood test for TBI, according to the company, helping the doctors to rule out need for a CT scan in patients with mild TBI.
TBIs are caused by blow or whiplash to the head and can pose risk of short- and long-term effects that can include impairment of memory and movement.
Abbott already has a plasma test for TBI and was cleared by the FDA in 2021.
The new test measures two indicators in the blood that, in elevated concentrations, are tightly correlated to brain injury, the company said. (Reporting by Raghav Mahobe in Bengaluru; Editing by Shailesh Kuber)
"Things continue to happen behind the curtain."
Yes, here is something that happened in 2022.
8/30/22 judgement issued by Riverside County CA, Superior Court:
For - CHERYL SCARINI SCHLOSS SPECIAL ADMINISTRATOR FOR THE ESTATE OF EDWARD JAMES SCHLOSS
Against - QUANTUM MATERIALS CORPORATION
Against - STEPHEN SQUIRES
Against - ROBERT PHILLIPS
Against - SOLTERRA RENEWABLE TECHNOLOGIES INC
9/15/22 judgement filed:
Principal---------------$2,555,899.44
Costs-------------------------$5,072.94
Accrued Interest--------$111,446.16
Attorney Fees--------$1,023,659.00
Subtotal Judgment--$3,696,077.54
Total---------------------$3,696,077.54
12/01/2022--Stipulation and Order to Continue Judgment Debtors' Examination Hearings is Granted on 1st Amended Complaint CHERYL SCARINI SCHLOSS SPECIAL ADMINISTRATOR FOR THE ESTATE OF EDWARD JAMES SCHLOSS
01/17/2023--Notice of ruling Denying Defendants' Motion to vacate default and default judgment on 1st Amended Complaint CHERYL SCARINI SCHLOSS SPECIAL ADMINISTRATOR FOR THE ESTATE OF EDWARD JAMES SCHLOSS
02/03/2023 08:30 AM--Hearing re: Judgment Debtor Examination as to QUANTUM MATERIALS CORPORATION
02/03/2023 08:30 AM--Hearing re: Judgment Debtor Examination as to STEPHEN SQUIRES
CASE NUMBER: PSC2002459
https://epublic-access.riverside.courts.ca.gov/public-portal/?q=node/369
My assumption is that the Judgement Debtor Examinations have been ordered based on QMC and Squires declaring that they don't have the funds to pay off the judgements against them.
Not confusing. There is a 72 hour window after the potential concussion to get the test completed. If you wait too long then the test results will not be valid or will give false results.
Once the blood sample is in the lab, that has the proper test equipment to perform the analysis of the blood sample, then it only takes 20 minutes to perform the actual test.
If you read the Neurolytis literature and the patent, the testing is done using mass spectrometry equipment, no QDs or LFDs.
No, what I showed was that the License Agreement called for $1 million in an Upfront License fee ($500K + $500K) and that AMTRON “confirming that the $1M USD upfront license fee would be paid to the Company on or before January 31, 2019.”
But the $1 million wasn’t paid in January, it was only partially paid ($500K) in March and they confirmed that they were still owed another $500K.
"Quote 3 it sure looks like shipment of these two units , installing of the two units, and certifying of the two units were all part of quote 1"
No, $1 million Upfront Fee plus another $1 million for purchase of 2 reactors.
"As of December 31, 2019 and June 30, 2019, contract liabilities were $1,197,973 and $500,000, respectively."
"Did the Head of the India project, Dr. George Anthony Balchin confirm the project is still a possibility earlier this year?"
Confirm? He stated that "it is our intention to complete the facility" but offered no info that would confirm that it is actually proceeding ahead.
No status of actual construction completed or future timeline. No mention of previous pre-fab work performed and sitting in storage (wonder if it was ever paid for), revised budget, or funding sources. A three year delay in construction usually results in significant cost overruns.
So we are now informed by looking at Google Earth Pro, that as of Aug 2022, AMTROM has been hard at work on their Tech City infrastructure projects and the start of the 9 story BPO tower.
Oct 31, 2021:
Aug 2022:
Here is a view of what Amtonics has accomplished over the same time frame on the Nano Factory building site.
Oct 31, 2021
Aug 2022
"Does Innova Medical Group state that QMC HealthID technology is incorporated in their app?"
It looks like Pasaca and Innova have updated their websites and have deleted any mention of QMC.
No, the SEC makes those notifications confidential. They give the companies the warning and allow the companies to regain compliance without the issue being broadcast.
The issue was QMC committed to the SEC to regain compliance by end of February but failed to do so.
Everyone knew that they were non-compliant with the reporting requirements and there was a known process in place for the SEC to take action and pull their registration. And the SEC did.
You can see what he owns here,
https://www.sec.gov/edgar/browse/?CIK=0001030874
I think the obvious explanation is that that photo from Jan 2019 is framed under glass and hanging on the wall inside the Tech City Camp Office. On April 4, 2022 AMTRON held their Foundation Day event partially at Tech City. See the other April photos on Google maps.
Looks like Bravo Delta took photos of the old pictures hanging on the wall in the Camp Office and posted the new photos of the old photos on Google Maps. Note the reflection of the windows off of the glass on the framed picture. In the reflections you can see the vertical security grating that wraps around the Camp Office porch and over the front windows.
No news about QMC nano or solar at this years Foundation Day event.
Also looks like AMTRON is re-focusing on their primary mission of Info Tech.
CtrlS breaks ground on new data center in Guwahati, Assam
And it shows even better on the up-to-date Superior Court website.
News of? or an actual S-1 filed with the SEC?
"So given the company did not say a thing"
RFB, on 2/10 Sigma issued a PR and an 8-K informing everyone that since the warrants were expiring on 2/22 that the NASDAQ would file a Form 25 with SEC on 2/17/22 to have the Warrants delisted.
Interview on 1/21/22.
https://omny.fm/shows/alan-carter/london-based-company-using-blood-test-and-ai-to-de
Clinical trial to start in April 2022.
Approval within one to one & one half years.
Looks like AMTRON is getting back to its core business, Information Technology.
Yes, Tech City is getting reestablished.
AMTRON committed to spending $17 million on a 9 story BPO Tower last August.
Total Stockholders’ Equity is reported in every quarterly report. You can see how it has changed over time by going to EDGAR.
I think they are just pulling one PCR test (CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel) that was authorized in Feb 2020. The other 268 authorized tests are still ok.
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2
Remember these announcements?
https://blog.citigroup.com/2021/03/bringing-rapid-at-home-covid-19-testing/
https://ir.liveperson.com/news-releases/news-release-details/liveperson-and-innova-medical-group-announce-partnership-ai
Whose app is Innova using?
One very small step.
On 11/1/21 QMC filed their annual list and their amended Articles of Incorporation with the State of Nevada. Their status is now Active, no longer Default.
2 Billion shares authorized as of 11/2/21.
https://esos.nv.gov/EntitySearch/BusinessFilingHistoryOnline
As others have pointed out, not QD solar cells. Per NREL:
P — Open market or private purchase of non-derivative or derivative security
He purchased shares, was not awarded shares.
QMC has at least $13.9 million in debt and Pasaca holds at least $7.25 million of that debt with Secured Notes.
That's why Pasaca is still hanging around.
and
10/27/2021 Motion to Compel Hearing (9:00 AM) (Judicial Officer Boyer, Bruce)
Really?
Was not approved or even voted on. Replaced by another proxy that just upped the A/S to 750,000,000 shares.
https://www.sec.gov/Archives/edgar/data/1403570/000149315217002462/pre14a.htm
Yes the shareholder update letter on 8/25/21.
https://www.globenewswire.com/news-release/2021/08/25/2286267/0/en/Quantum-Materials-Shareholder-Update.html
Innova website update:
https://innovamedgroup.com
After:
The computation based on the Jan 2021 & 10-K numbers was just over 2 billion so I expected they would bump it up to 2.5 to give them at least a 20% margin for future use after Pasaca completed their buy-in.
Now it looks to me like they are not expecting Pasaca to complete the buy-in but they are asking for an extra 50% margin for future private placements with Pasaca or others to support continued operations.
"I don't believe anyone knows what his salary is."
From the last 10-K
"when they state “convertible debt 407 million shares” it doesn’t include Pasaca’s $7.25 million convertible notes?"
No, The $13.9 million of convertible debt (convertible into 407 million shares) includes Pasaca's $7.25 million which is convertible into 249 million shares. That is why I subtracted the 249 million shares from the fully diluted share when calculating the 49%.
Here is an update of my previous post based on additional info from the 8/30/21 Consent Solicitation.
https://f.hubspotusercontent10.net/hubfs/5830511/Definitive_14a_8-30-21%204836-9107-1731%20v7.pdf
Determine minimum number of Authorized Shares needed to give Pasaca 51% of fully diluted shares after Second Closing.
704,569,276 Outstanding shares as of 8/30/21 (from CONSENT SOLICITATION)
+ 13,505,535 unissued outstanding shares
+ 63,983,453 (=7,900,000+46,733,453+9,350,000) outstanding options in Plans
+ 56,350,000 outstanding options not in Plans
+ 51,335,063 outstanding warrants
+407,426,390 convertible debt
=1,297,169,717 fully dilute shares as of 8/30/21 (“current”)
The “current” total diluted shares will make up 49% of the “new” fully diluted shares after the Pasaca completes their buy-in. Therefore, divide the “current” fully diluted shares by 0.49 to determine the “new” fully diluted shares.
(1,297,169,717 – 249,661,287) / 0.49 = 2,137,772,306
Then determine the total number of shares that Pasaca will need to give them 51% of the new fully diluted shares by multiplying by 0.51.
2,137,772,306 x 0.51 = 1,090,263,876 Pasaca’s total shares
According to the CONSENT SOLICITATION, Pasaca beneficially owns 257,277,338 shares of common stock issuable upon conversion of their debentures and interest.
To determine the number of shares that Pasaca needs to purchase at the Second Closing to give them 51%, start by subtracting the Senior Note conversion shares from Pasaca’s total shares.
1,090,263,876
-257,277,338
832,986,543
Therefore Pasaca would convert the $7.25 million in notes into 257,277,388 shares ($0.029 per share) and would pay $7.75 million for the additional 832,986,543 shares ($0.0093 per share) at the second closing to give them 51% of the new fully diluted shares (combined avg of $0.0138 per share).
So Authorized Shares needs to be above 2.1 billion to complete the Pasaca agreement, and since the Consent is only asking for A/S of 2.0 billion, then my conclusion is that Pasaca will not complete the deal and end up owning 51% of QMC. Pasaca does hold $7,250,000 in secured convertible Notes and will continue to accrue 8% interest on the Notes for now.
With current fully diluted shares at about 1.3 billion, the increase in A/S to 2.0 billion leaves QMC with about 700,000,000 shares to finance continuing operations with.
Previous Post:
Ya, should have been:
Further discussion on the status of QMC's solar cell design.
In Sept 2018 QMC announced their capability to mass produce high performance, low cost perovskite quantum dots - paving the way for next generation solar ... applications incorporating PQD materials.
"- Does the company have a demonstrated, commercially viable QDSC design and manufacturing process?"